HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.

AbstractAIM:
MOGS mutations cause congenital disorders of glycosylation type IIb (CDG-IIb or GCS1-CDG). The specific manifestations caused by the mutations in this gene remain unknown. We aimed to describe the clinical features of CDG- IIb and the effectiveness of urinary oligosaccharide analysis in the diagnosis of CDG- IIb.
METHODS:
Patient 1 was analyzed with whole-exome sequencing (WES) to identify the causative gene of intractable epilepsy and severe developmental delay. After detecting MOGS mutation in patient 1, we analyzed patients 2 and 3 who were siblings and had clinical features similar to those in patient 1. Urinary oligosaccharide analysis was performed to confirm CDG- IIb diagnosis in patient 1. The clinical features of these patients were analyzed and compared with those in eight published cases.
RESULTS:
Our three patients presented with early infantile epileptic encephalopathy, generalized hypotonia, hepatic dysfunction and dysmorphic features. In two cases, compound heterozygous mutations in MOGS were identified by WES. Isolation and characterization of the urinary oligosaccharide was performed in one of these cases to confirm the diagnosis of CDG-IIb. Although the isoelectric focusing of transferrin (IEF-T) of serum in this patient was normal, urinary excretion of Hex4 corresponding to Glc3Man was observed by mass spectrometry.
CONCLUSION:
This report provides clinical manifestations of CDG-IIb with MOGS mutation. CDG-IIb shows a normal IEF profile of serum transferrin and cannot be detected by structural analysis of the patient's glycoproteins. Characterization of urinary oligosaccharides should be considered to detect this disorder.
AuthorsRie Anzai, Megumi Tsuji, Sumimasa Yamashita, Yoshinao Wada, Nobuhiko Okamoto, Hirotomo Saitsu, Naomichi Matsumoto, Tomohide Goto
JournalBrain & development (Brain Dev) Vol. 43 Issue 3 Pg. 402-410 (Mar 2021) ISSN: 1872-7131 [Electronic] Netherlands
PMID33261925 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • glucosidase I
  • alpha-Glucosidases
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Congenital Disorders of Glycosylation (complications, genetics)
  • Craniofacial Abnormalities (genetics)
  • Female
  • Humans
  • Infant
  • Liver Diseases (genetics)
  • Male
  • Mutation
  • Spasms, Infantile (genetics)
  • alpha-Glucosidases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: